Alder BioPharmaceuticals® appoints Erin Lavelle to newly created role of COO
Alder BioPharmaceuticals announced it has appointed Erin Lavelle to the newly created role of Chief Operating Officer. Ms. Lavelle brings to Alder 20 years of cross-functional experience leading strategic and operational initiatives in the biopharmaceutical industry. April 16, 2018